SCHEMBL25518708

SCHEMBL25518708

CCCCC(CCCC)c1ccccc1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
CYSLTR2 Q9NS75 1/20 0.42
CYSLTR1 Q9Y271 1/20 0.42
ALDH1A1 P00352 3/20 0.39
HSD17B10 Q99714 2/20 0.38
DHFR P00374 1/20 0.37
EGFR P00533 1/20 0.37
POLB P06746 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP3A4 P08684 1/20 0.35
ALOX15 P16050 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CSNK1E P49674 1/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25521022 0.94 CYSLTR2 (0.46) CYP1A2CYP2C9CYP2C19CYSLTR2CYSLTR1
SCHEMBL4688464 0.92 CYSLTR2 (0.47) CYP1A2CYP2C9CYP2C19CYSLTR2CYSLTR1
SCHEMBL20711188 0.92 CYSLTR2 (0.47) CYP1A2CYP2C9CYP2C19CYSLTR2CYSLTR1
SCHEMBL20711189 0.92 CYP1A2 (0.42) CYP1A2CYP2C9CYP2C19CYSLTR2CYSLTR1
SCHEMBL28110318 0.92 CYSLTR2 (0.47) CYP1A2CYP2C9CYP2C19CYSLTR2CYSLTR1
SCHEMBL11350827 0.92 CYSLTR2 (0.47) CYP1A2CYP2C9CYP2C19CYSLTR2CYSLTR1
SCHEMBL5875326 0.92 CYSLTR2 (0.47) CYP1A2CYP2C9CYP2C19CYSLTR2CYSLTR1
Water SCHEMBL7553028 0.91 CYSLTR2 (0.46) CYP1A2CYP2C9CYP2C19CYSLTR2CYSLTR1
SCHEMBL14747967 0.91 CYSLTR2 (0.42) CYP1A2CYP2C9CYP2C19CYSLTR2CYSLTR1
SCHEMBL25475053 0.89 CYSLTR2 (0.44) CYP1A2CYP2C9CYP2C19CYSLTR2CYSLTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159569-A1 DUAL HDAC6/PROTEASOME INHIBITORS, AND METHODS OF USE THEREOF UNIVERSITY OF MARYLAND, BALTIMORE (US) 2023-05-25 US disclosed
CN-109384981-A Modified conjugated diene rubber composition and tire 旭化成株式会社 2019-02-26 CN disclosed
CN-109384982-A Modified conjugated diene polymer composition and tire 旭化成株式会社 2019-02-26 CN disclosed
CN-108164645-A MODIFIED CONJUGATED DIENE POLYMER, MODIFIED CONJUGATED DIENE POLYMER COMPOSITION AND TIRE 旭化成株式会社 2018-06-15 CN disclosed
CN-107250172-A Modified conjugated diene polymer and its manufacture method and modified conjugated diene polymer composition 旭化成株式会社 2017-10-13 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159569-A1 DUAL HDAC6/PROTEASOME INHIBITORS, AND METHODS OF USE THEREOF HDAC6, PSMG3, PSMB2 CYP1A2 4623/4885CYP2C9 4849/4885CYP2C19 4808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.